☰

Rachel L. Nosheny, Ph.D. - Publications

Affiliations: 
2006 Georgetown University Medical Center, Washington, DC, United States 
Area:
Neuroscience Biology, Virology Biology
Tree Info Grants Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Nosheny RL, Jin C, Neuhaus J, Insel PS, Mackin RS, Weiner MW. Study partner-reported decline identifies cognitive decline and dementia risk. Annals of Clinical and Translational Neurology. PMID 31721455 DOI: 10.1002/Acn3.50938  0.307
2019 Camacho MR, Grill JD, Karlawish J, Rabinovici GD, Carrillo MC, Weiner MW, Nosheny RL. P1-351: COGNITIVELY IMPAIRED BRAIN HEALTH REGISTRY PARTICIPANTS’ ATTITUDES ABOUT THE VALUE OF AMYLOID PET RESULTS Alzheimer's & Dementia. 15: P385-P385. DOI: 10.1016/J.Jalz.2019.06.906  0.347
2019 Weiner MW, Nosheny RL, Mackin RS, Truran-Sacrey D, Flenniken D, Camacho MR, Kwang W, Howell T, Fockler J, Alosco ML, Stern RA, Montine TJ, Cholerton B, Ashford JW, Maruff P, et al. S4-01-01: IDENTIFYING ELDERS AT RISK FOR COGNITIVE DECLINE USING THE BRAIN HEALTH REGISTRY (BHR) Alzheimer's & Dementia. 15: P1215-P1215. DOI: 10.1016/J.Jalz.2019.06.4709  0.341
2018 Mackin RS, Insel PS, Truran D, Finley S, Flenniken D, Nosheny R, Ulbright A, Comacho M, Bickford D, Harel B, Maruff P, Weiner MW. Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 573-582. PMID 30406176 DOI: 10.1016/J.Dadm.2018.05.005  0.336
2018 Nosheny RL, Camacho MR, Insel PS, Flenniken D, Fockler J, Truran D, Finley S, Ulbricht A, Maruff P, Yaffe K, Mackin RS, Weiner MW. Online study partner-reported cognitive decline in the Brain Health Registry. Alzheimer's & Dementia (New York, N. Y.). 4: 565-574. PMID 30386821 DOI: 10.1016/J.Trci.2018.09.008  0.347
2017 Zwan MD, Flenniken D, Finley S, Nosheny R, Sikkes SA, van der Flier WM, Scheltens P, Weiner M, Prins ND. [P2-052]: THE DUTCH BRAIN HEALTH REGISTRY: OPTIMIZING RECRUITMENT FOR DEMENTIA RESEARCH Alzheimer's & Dementia. 13: P624-P624. DOI: 10.1016/J.Jalz.2017.06.701  0.313
2016 Nosheny RL, Flenniken D, Insel PS, Mackin S, Finley S, Camacho MR, Truran-Sacrey D, Ulbricht A. P4-005: SELF-REPORTED APOE GENOTYPE IN THE BRAIN HEALTH REGISTRY: ASSOCIATIONS WITH MEMORY AND ASSESSMENT OF APOE 4+ PARTICIPANTS ELIGIBLE FOR ALZHEIMER'S DISEASE CLINICAL TRIALS Alzheimer's & Dementia. 12: P1015-P1016. DOI: 10.1016/J.Jalz.2016.06.2094  0.315
2015 Insel PS, Mattsson N, Mackin RS, Kornak J, Nosheny R, Tosun-Turgut D, Donohue MC, Aisen PS, Weiner MW. Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease. Annals of Clinical and Translational Neurology. 2: 534-47. PMID 26000325 DOI: 10.1002/Acn3.192  0.32
2015 Nosheny RL, Insel PS, Truran D, Schuff N, Jack CR, Aisen PS, Shaw LM, Trojanowski JQ, Weiner MW. Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment. Neurobiology of Aging. 36: 273-82. PMID 25175807 DOI: 10.1016/J.Neurobiolaging.2014.07.036  0.305
2015 Nosheny RL, Flennkiken D, Insel PS, Finley S, Mackin S, Camacho M, Truran-Sacrey D, Maruff P, Weiner MW. O1-10-06: Internet-based recruitment of subjects for prodromal and secondary prevention Alzheimer's disease trials using the brain health registry Alzheimer's & Dementia. 11: P156-P156. DOI: 10.1016/J.Jalz.2015.07.086  0.318
2015 Weiner MW, Nosheny RL, Flennkiken D, Insel PS, Finley S, Mackin S, Camacho M, Truran-Sacrey D. P1-318: Internet-based recruitment and screening of subjects for ad trials using longitudinal data from the brain health registry Alzheimer's & Dementia. 11: P478-P479. DOI: 10.1016/J.Jalz.2015.06.533  0.304
2015 Insel PS, Mattsson N, Mackin S, Kornak J, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Weiner MW. P4-135: Inclusion criteria and cognitive responses to optimize trials in Alzheimer's disease Alzheimer's & Dementia. 11: P829-P830. DOI: 10.1016/J.Jalz.2015.06.1841  0.305
2014 Mattsson N, Insel PS, Nosheny R, Tosun D, Trojanowski JQ, Shaw LM, Jack CR, Donohue MC, Weiner MW. Emerging β-amyloid pathology and accelerated cortical atrophy. Jama Neurology. 71: 725-34. PMID 24781145 DOI: 10.1001/Jamaneurol.2014.446  0.337
2014 Mattsson N, Insel P, Nosheny R, Trojanowski JQ, Shaw LM, Jack CR, Tosun D, Weiner M. Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults. Neurobiology of Aging. 35: 614-22. PMID 24094581 DOI: 10.1016/J.Neurobiolaging.2013.08.027  0.363
2014 Dang V, Medina B, Das D, Moghadam S, Martin KJ, Lin B, Naik P, Patel D, Nosheny R, Wesson Ashford J, Salehi A. Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome. Biological Psychiatry. 75: 179-88. PMID 23827853 DOI: 10.1016/J.Biopsych.2013.05.024  0.325
2013 Mattsson N, Insel P, Nosheny R, Zetterberg H, Trojanowski JQ, Shaw LM, Tosun D, Weiner M. CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders. Translational Psychiatry. 3: e293. PMID 23962923 DOI: 10.1038/Tp.2013.69  0.324
2013 Nosheny R, Insel P, Truran D, Schuff N, Jack C, Aisen P, Petersen R, Jagust W, Shaw L, Trojanowski J, Weiner M. P1-158: The effect of age and amyloid status on hippocampal atrophy rate in normal controls and people with mild cognitive impairment in the ADNI cohort Alzheimer's & Dementia. 9: P207-P207. DOI: 10.1016/J.Jalz.2013.05.381  0.317
2008 Bachis A, Cruz MI, Nosheny RL, Mocchetti I. Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex. Neuroscience Letters. 442: 104-8. PMID 18621098 DOI: 10.1016/J.Neulet.2008.06.081  0.507
2007 Mocchetti I, Nosheny RL, Tanda G, Ren K, Meyer EM. Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system. Annals of the New York Academy of Sciences. 1122: 144-54. PMID 18077570 DOI: 10.1196/Annals.1403.010  0.626
2007 Mocchetti I, Bachis A, Nosheny RL, Tanda G. Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons. Neurotoxicity Research. 12: 135-43. PMID 17967737 DOI: 10.1007/Bf03033922  0.62
2007 Nosheny RL, Ahmed F, Yakovlev A, Meyer EM, Ren K, Tessarollo L, Mocchetti I. Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo. The European Journal of Neuroscience. 25: 2275-84. PMID 17445226 DOI: 10.1111/J.1460-9568.2007.05506.X  0.619
2006 Nosheny RL, Bachis A, Aden SA, De Bernardi MA, Mocchetti I. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. Journal of Neurobiology. 66: 1311-21. PMID 16967504 DOI: 10.1002/Neu.20288  0.642
2006 Bachis A, Aden SA, Nosheny RL, Andrews PM, Mocchetti I. Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 6771-80. PMID 16793884 DOI: 10.1523/Jneurosci.1054-06.2006  0.635
2005 Nosheny RL, Mocchetti I, Bachis A. Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotoxicity Research. 8: 187-98. PMID 16260395 DOI: 10.1007/Bf03033829  0.652
2004 Nosheny RL, Bachis A, Acquas E, Mocchetti I. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. The European Journal of Neuroscience. 20: 2857-64. PMID 15579139 DOI: 10.1111/J.1460-9568.2004.03764.X  0.645
2004 Acquas E, Bachis A, Nosheny RL, Cernak I, Mocchetti I. Human immunodeficiency virus type 1 protein gp120 causes neuronal cell death in the rat brain by activating caspases. Neurotoxicity Research. 5: 605-15. PMID 15111237 DOI: 10.1007/Bf03033180  0.632
Show low-probability matches.